Renal Hypertrophy in Hyperglycemic Non-Obese Diabetic Mice Is Associated with Persistent Renal Accumulation of Insulin-Like Growth Factor I

Journal of the American Society of Nephrology

Volumn 8, Issue 3, 1997, Pages 436-444

  Segev, Yael ^a   Landau, Daniel ^a   Marbach, Miriam ^a   Shehadeh, Naim ^b   Flyvbjerg, Allan ^c   Phillip, Moshe ^a,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c Aarhus Kommunehospital   (Denmark)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL; ARTICLE; BLOOD; FEMALE; GENETICS; HYPERGLYCEMIA; HYPERTROPHY; KIDNEY; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; ORGAN SIZE; PATHOLOGY;

ANIMALS; FEMALE; HYPERGLYCEMIA; HYPERTROPHY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MICE; MICE, INBRED NOD; ORGAN SIZE; RECEPTORS, SOMATOMEDIN; RNA, MESSENGER;

EID: 0031092351     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. US Renal Data System: Excerpts from United States Renal Data System 1996 Annual Data Report: Incidence and Prevalence of ESRD. Am J Kidney Dis 28: S34-S47, 1996
2. Wiseman MJ, Mangili R, Alberetto M, Keen H, Viberti G: Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int 31: 1012-1018, 1987
3. Seyer-Hansen K, Hansen J, Gundersen HJG: Renal hypertrophy in experimental diabetes: A morphometric study. Diabetologia 18: 501-505, 1980
4. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981
5. Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45: 612-622, 1994
6. Steffes MW, Østerby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989
7. Mogensen CE, Andersen MJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706-712, 1983
8. Viberti GC: Early functional and morphological changes in diabetic nephropathy. Clin Nephrol 12: 47-53, 1979
9. LeRoith D, Adamo M, Werner H, Roberts CT Jr: Insulin-like growth factors, their binding proteins and receptors as growth regulators in normal physiology and pathological states. Trends Endrocrinol Metab 2: 134-139, 1991
10. Conti FG, Striker LJ, Lesniak MA, MacKay K, Roth J, Striker GE: Studies on binding and mitogenic effects of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology 122: 2788-2795, 1988
11. Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82, 1993
12. D'Ercole AJ: Somatomedins/insulin-like growth factors and fetal growth. J Dev Physiol 9: 481-495, 1987
13. Rechler MM, Nissley SP: The nature and regulation of the receptor for insulin-like growth factors. Annu Rev Physiol 47: 425-442, 1985
14. Chin E, Zhou J, Bondy C: Anatomical relationships in the patters of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 130: 3237-3245, 1992
15. Arnqvist HJ, Ballerman BJ, King GL: Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am J Physiol 254: C411-C416, 1988
16. Pillion DJ, Haskell JF, Meezan E: Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubuli. Am J Physiol 255: E504-E508, 1988
17. Clemmons DR: IGF binding proteins: Regulation of cellular actions. Growth Regul 2: 80-87, 1992
18. Busby WH, Klapper DG, Clemmons DR: Purification of a 31,000 dalton insulin-like growth factor bidning protein from human amniotic fluid. J Biol Chem 263: 14203-14210, 1988
19. De Mellow JSM, Baxter RC: Growth hormone-dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochem Biophys Res Commun 156: 199-204, 1988
20. Flyvbjerg A, Thorlacius-Ussing O, Naeraa R, Ingerslev J, Ørskov H: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31: 310-314, 1988
21. Bach LA, Jerums G: Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 39: 557-562, 1990
22. Lajara R, Rotwein P, Brotz JD, Hansen VA, Sadow JL, Betts CR, Rogers SA, Hammerman MR: Dual regulation of insulin-like growth factor I expression during renal hypertrophy. Am J Physiol 257: F252-F26L, 1989
23. Landau D, Domene H, Shen Orr Z, Laron Z, LeRoith D, Roberts CT Jr: Effect of GH status on renal Insulin-like growth factor I (IGF-I), IGF-I receptor (IGF-IR), IGF binding proteins (IGFBP) and growth hormone receptor (GHR) mRNA levels in prepubertal rats. Endocrinol J 2: 611-616, 1994
24. Guler HP, Zapf J, Scheiwiller E, Froesch ER: Recombinant human insulin-like growth factor stimulates growth and has direct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85: 4889-4893, 1988
25. Kempe HP, Engelmann K, Grietz N, Hasslacher C: Models of diabetes for studying diabetic nephropathy. In: Experimental and Genetic Rat Models of Chronic Renal Failure, edited by Gretz N, Strauch M, Basel, Karger, 1993, pp 148-151
26. Pour PM, Duckworth W, Carlson K, Kazakoff K: Insulin therapy prevents spontaneous recovery from streptozotocin-induced diabetes in Syrian hamsters: An autoradiographic and immunohistochemical study. Virchows Arch A Pathol Anat 417: 333-341, 1990
27. Wang RN, Bouwens L, Kloppel G: Beta-cell proliferation in normal and streptozotocin-treated newborn rats. Diabetologia 37: 1088-1096, 1994
28. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J 4: 2850-2859, 1990
29. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13, 1980
30. Wicker L, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from the non-obese diabetic (NOD) mice. Diabetes 35: 855-860, 1986
31. Tochino Y: Breeding and characteristics of a spontaneously diabetic nonobese strain (NOD mouse) of mice. In: Lessons from Animal Diabetes, edited by Shafrir E, Renold AE, London, John Libbey, 1984, p 93
32. Doi T, Hattori M, Agodoa YC, Sato T, Yoshida H, Striker L, Striker G: Gomerular lesions in nonobese diabetic mouse: Before and after the onset of hyperglycemia. Lab Invest 63: 204-212, 1990
33. Hossenlopp P, Seurin S, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138-143, 1986
34. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W: Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35: 589-593, 1992
35. Phillip M, Palese A, Hernandez ER, Roberts CT Jr, LeRoith D, Kowarski A: Effect of testosterone on IGF-I receptor gene expression in the hypophysectomized rat. Endocrinology 130: 2865-2870, 1992
36. Lowe WL Jr, Roberts CT Jr, Lasky SR, LeRoith D: Differential expression of alternative 5′-untranslated regions in mRNA encoding at insulin-like growth factor I. Proc Natl Acad Sci USA 84: 8946-8950, 1987
37. Lowe WL Jr, Lasky SR, LeRoith D, Roberts CT Jr: Distribution and regulation of insulin-like growth factor I mRNAs encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in the liver. Mol Endocrinol 2: 528-535, 1988
38. Kobayashi S, Clemmons DR, Nogami H, Roy AK, Venkatachalam MA: Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-I and IGFBP-1. Kidney Int 47: 818-828, 1995
39. Flyvbjerg A, Marshall SM, Frystyk J, Rasch R, Bornfeldt KE, Arnqvist HJ, Jensen PK, Pallesen G, Ørskov H: Insulin-like growth factor I in initial renal hypertrophy in potassium depleted rats. Am J Physiol 265: F1-F14, 1992
40. Mulroney SE, Haramati A, Werner H, Bondy C, Roberts CT, LeRoith D: Altered expression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes after unilateral nephrectomy in immature rats. Endocrinology 130: 249-256, 1992
41. Rogers SA, Miller SB, Hammerman MR: Enhanced renal IGF-I expression following partial kidney infarction. Am J Physiol 264: F963-F967, 1993
42. Phillip M, Werner H, Palese T, Kowarski AA, Stene M: Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats. J Mol Endocrinol 12: 215-224, 1994
43. Flybjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Ørskov H: Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 33: 334-338, 1990
44. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 266: F829-F842, 1994
45. Landau D, Chin E, Bondy C, Domene H, Roberts CT Jr, Grønbaek H, Flyvbjerg A, LeRoith D: Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes. Endocrinology 136: 1835-1842, 1995
46. Shimasaki S, Shimonaka M. Zhang HP, Ling N: Isolation and molecular characterization of three novel insulin like growth factor binding proteins (IGFBP-4, -5 and -6). In: Modern Concepts of Insulin Like Growth Factors, edited by Spencer EM, New York, Elsevier, 1991, pp 343-358
47. Barreca A, Arvigo M, Melloni E, Giordano G, Minuto F: Purification and partial characterization of proteases for the insulin-like growth factore binding protein 3 (IGFBP-3): Role of the kidney on the regulation of IGF bioactivity. Third International Symposium on insulin-like growth factor binding proteins, Tübingen, Germany, October 6-8, 1995
48. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66: 266-272, 1988
49. Werner H, Shen Orr Z, Stannard B, Burguera B, Roberts CT Jr, LeRoith D: Experimental diabetes increases insulin like growth factor-I and II receptor concentration in kidney. Diabetes 39: 1490-1497, 1990
50. Young BE, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
51. Pankewicz OG, Guan JX, Bolton WK, Gomez A, Benedict JF: Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 46: 748-758, 1994
52. Shankland SJ, Scholey JW, Ly H, Thai K: Expression of transforming growth factor β1 during diabetic renal hypertrophy. Kidney Int 45: 430-442, 1994
53. Shankland SJ, Scholey JW, Ly H, Thai K: Expression of growth related protooncogenes during diabetic renal hypertrophy. Kidney Int 47: 782-788, 1995
54. Doi T, Striker LJ, Quafe C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker G: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those insulin-like growth factor-I. Am J Pathol 131: 398-403, 1988
55. Young CW, Striker LJ, Pesce C, Chen WY, Peten EP, Elliot S, Doi T, Kopchick JJ, Striker GE: Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone: Studies in transgenic mice. Lab Invest 68: 62-70, 1993
56. El Nahas AM, Bassett AH, Cope GH, Le Carpentier JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 40: 29-34, 1991